Edwards Lifesciences Corp. Stock Rises Wednesday, Still Underperforms Market

Dow Jones
2024-12-12

DJ Edwards Lifesciences Corp. Stock Rises Wednesday, Still Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Edwards Lifesciences Corp. $(EW)$ inched 0.57% higher to $73.81 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.82% to 6,084.19 and the Dow Jones Industrial Average falling 0.22% to 44,148.56.

This was the stock's second consecutive day of gains.

Edwards Lifesciences Corp. closed $22.31 below its 52-week high ($96.12), which the company reached on March 28th.

The stock outperformed some of its competitors Wednesday, as Abbott Laboratories $(ABT)$ fell 1.18% to $114.14, Medtronic PLC $(MDT)$ fell 0.79% to $82.92, and Stryker Corp. $(SYK)$ fell 1.70% to $376.16.

Trading volume (3.5 M) remained 1.7 million below its 50-day average volume of 5.2 M.

Data source: Dow Jones Market Data, FactSet. Data compiled December 11, 2024.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

December 11, 2024 16:55 ET (21:55 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10